Rare diseases
Investigational molecules
Locations
Fliethstrasse 112-114, Stadtmitte, 41061 Moenchengladbach, Germany
WSG Westdeutsche Studiengruppe GmbH focuses on treatment strategies for early breast cancer across multiple molecular subtypes, including ER+/HER2-, HR+/HER2-, HER2+, and triple-negative breast cancer. The research portfolio includes both neoadjuvant therapy and adjuvant therapy settings.
Key interests include risk-adapted treatment selection for patients with intermediate- and high-risk disease, with attention to recurrence prevention and long-term disease control.
WSG Women's Cancer Study Group GmbH runs clinical trials in conditions such as Breast cancer female, Breast cancer, Hormone receptor positive breast cancer, Breast cancer male, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
Austria
BelgiumGermanyGermanyGermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
